Kovack Advisors, Inc. Kempharm, Inc Transaction History

Kovack Advisors, Inc.

$988 Million
Q2 2025

A detailed history of Kovack Advisors, Inc. transactions in Kempharm, Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 146,788 shares of KMPH stock, worth $725,132. This represents 0.07% of its overall portfolio holdings.

Number of Shares

146,788

Previous 146,747 0.03%

Holding current value

$725,132

Previous $724,000 0.14%

% of portfolio

0.07%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	N/A	41 Added 0.03%	146,788 $725,000
Q1 2025 May 06, 2025	BUY	N/A	589 Added 0.4%	146,747 $724,000
Q4 2024 Feb 04, 2025	SELL	N/A	-2,644 Reduced 1.78%	146,158 $722,000
Q3 2024 Nov 05, 2024	SELL	N/A	-730 Reduced 0.49%	148,802 $735,000
Q2 2024 Aug 02, 2024	BUY	N/A	7,686 Added 5.42%	149,532 $738,000
Q1 2024 Apr 19, 2024	BUY	N/A	445 Added 0.31%	141,846 $700,000
Q4 2023 Feb 02, 2024	BUY	N/A	17,292 Added 13.93%	141,401 $698,000
Q3 2023 Oct 19, 2023	BUY	N/A	2,791 Added 2.3%	124,109 $613,000
Q2 2023 Jul 21, 2023	SELL	$4.94 - $6.29 $7,429 - $9,460	-1,504 Reduced 1.22%	121,318 $599,000
Q1 2023 Apr 20, 2023	BUY	$4.13 - $6.27 $65,576 - $99,555	15,878 Added 14.85%	122,822 $675,000
Q4 2022 Feb 22, 2023	SELL	$4.12 - $5.62 $8,693 - $11,858	-2,110 Reduced 1.93%	106,944 $490,000
Q3 2022 Nov 14, 2022	BUY	$4.5 - $6.85 $103,338 - $157,303	22,964 Added 26.67%	109,054 $680,000
Q2 2022 Aug 10, 2022	SELL	$4.02 - $5.21 $49,172 - $63,728	-12,232 Reduced 12.44%	86,090 $384,000
Q1 2022 May 16, 2022	BUY	$5.0 - $9.26 $50,125 - $92,831	10,025 Added 11.35%	98,322 $494,000
Q4 2021 Jan 18, 2022	BUY	$7.6 - $10.26 $152,281 - $205,579	20,037 Added 29.35%	88,297 $769,000
Q3 2021 Nov 03, 2021	BUY	$8.72 - $13.31 $68,722 - $104,896	7,881 Added 13.05%	68,260 $637,000
Q2 2021 Jul 29, 2021	BUY	$8.52 - $15.47 $514,429 - $934,063	60,379 New	60,379 $774,000

Others Institutions Holding KMPH

# of Institutions

138

Shares Held

32.9M

Call Options Held

3.61M

Put Options Held

621K

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Kempharm, Inc Transaction History